Blog

ProSci aims to help researchers with
difficult antigen targets

We take pride in being able to make challenging antibodies, including anti-idiotypic antibodies, antibodies against small molecules, or even antibodies against modified proteins. With over 20,000 completed projects, we can create monoclonal and polyclonal antibodies against various difficult target antigen types. As a research-oriented company, we continue to expand our own custom antibody development as well, focusing our endeavors on single domain antibody development with llamas. Our experiences and expertise are tools for researchers in developing antibodies for virtually any desired application.

Here are some difficult antigen types that ProSci has had success working with:

ProSci Recombinant Protein Antigen ProSci Membrane Fraction Antigen ProSci Phospho Peptide Antigen ProSci Carbohydrate Antigen

Recombinant Protein

 

Membrane Fraction

 

Phosphopeptide

 

Carbohydrate

ProSci Anti-idiotypic antibody ProSci Peptide Antigen ProSci whole cell antigen

Antibody Variable Region (anti-idiotypic)

 

Small Molecule

 

Peptide

 

Whole Cell

ProSci’s HIV vaccine research program works on developing neutralizing antibodies against one of the most difficult antigen targets, the viral glycan shield. To accomplish this goal, we continue to explore and develop new technologies and evaluate novel adjuvants.

Feel free to review some of our case studies highlighting difficult antigen targets.

Free consultation on developing antibodies with difficult targets is available. To speak with our antibody experts, please call (888) 513-9525, or find out more about ProSci’s antibody production and custom antibody services here.

Interested in Collaboration?

ProSci is seeking potential academic and business collaborations in development of custom antibodies, including single domain llama antibodies (VHH). We look forward to providing both outstanding products and services and sharing ideas. Please contact us today with any questions!

Share this post: